|
1
|
28
|
6zgoL |
Thrombin in complex with d-phe-pro-2-chlorofuran derivative (13l) |
|
56
|
259
|
6zgoH |
Thrombin in complex with d-phe-pro-2-chlorofuran derivative (13l) |
|
1
|
28
|
6ysxL |
Thrombin in complex with 4-amino-n-(5-methylisoxazol-3-yl)benzenesulfonamide (j80) |
|
1
|
28
|
6ysjL |
Thrombin in complex with 2-amino-1-(4-bromophenyl)ethan-1-one (j10) |
|
57
|
257
|
6ysxH |
Thrombin in complex with 4-amino-n-(5-methylisoxazol-3-yl)benzenesulfonamide (j80) |
|
57
|
257
|
6ysjH |
Thrombin in complex with 2-amino-1-(4-bromophenyl)ethan-1-one (j10) |
|
0
|
10
|
6ysjI |
Thrombin in complex with 2-amino-1-(4-bromophenyl)ethan-1-one (j10) |
|
0
|
10
|
6ysxI |
Thrombin in complex with 4-amino-n-(5-methylisoxazol-3-yl)benzenesulfonamide (j80) |
|
51
|
257
|
7ntuB |
X-ray structure of the complex between human alpha thrombin and two duplex/quadruplex aptamers: nu172 and hd22_27mer |
|
3
|
28
|
7ntuA |
X-ray structure of the complex between human alpha thrombin and two duplex/quadruplex aptamers: nu172 and hd22_27mer |
|
3
|
28
|
6yqvL |
Thrombin in complex with 5-chlorothiophene-2-sulfonamide (j94) |
|
0
|
11
|
6yqvI |
Thrombin in complex with 5-chlorothiophene-2-sulfonamide (j94) |
|
58
|
257
|
6yqvH |
Thrombin in complex with 5-chlorothiophene-2-sulfonamide (j94) |
|
0
|
11
|
6ympI |
Thrombin in complex with 3-((5-(tert-butyl)isoxazol-3-yl)methyl)oxetan-3-amine (j54) |
|
56
|
257
|
6yn3H |
Thrombin in complex with 4-hydroxybenzamide (j89) |
|
1
|
28
|
6yn3L |
Thrombin in complex with 4-hydroxybenzamide (j89) |
|
2
|
28
|
6ympL |
Thrombin in complex with 3-((5-(tert-butyl)isoxazol-3-yl)methyl)oxetan-3-amine (j54) |
|
58
|
258
|
6ympH |
Thrombin in complex with 3-((5-(tert-butyl)isoxazol-3-yl)methyl)oxetan-3-amine (j54) |
|
0
|
10
|
6yn3I |
Thrombin in complex with 4-hydroxybenzamide (j89) |
|
56
|
258
|
6yhjH |
Thrombin in complex with d-phe-pro-2-chlorothiophen derivative (16e) |
|
2
|
30
|
6yhjL |
Thrombin in complex with d-phe-pro-2-chlorothiophen derivative (16e) |
|
0
|
11
|
6yhjI |
Thrombin in complex with d-phe-pro-2-chlorothiophen derivative (16e) |
|
1
|
28
|
6yb6L |
Thrombin in complex with d-phe-pro-3-chloro-1,3-dihydroxybenzylamide derivative (13c) |
|
56
|
257
|
6yb6H |
Thrombin in complex with d-phe-pro-3-chloro-1,3-dihydroxybenzylamide derivative (13c) |
|
0
|
11
|
6yhgI |
Thrombin in complex with d-phe-pro-m-methoxybenzylamide derivative (16a) |
|
57
|
258
|
6yhgH |
Thrombin in complex with d-phe-pro-m-methoxybenzylamide derivative (16a) |
|
0
|
11
|
6yb6I |
Thrombin in complex with d-phe-pro-3-chloro-1,3-dihydroxybenzylamide derivative (13c) |
|
0
|
11
|
6y9hI |
Thrombin in complex with d-phe-pro-m-trifluoromethylbenzylamide derivative (phe2) |
|
57
|
257
|
6y9hH |
Thrombin in complex with d-phe-pro-m-trifluoromethylbenzylamide derivative (phe2) |
|
1
|
31
|
6yhgL |
Thrombin in complex with d-phe-pro-m-methoxybenzylamide derivative (16a) |
|
1
|
28
|
6y9hL |
Thrombin in complex with d-phe-pro-m-trifluoromethylbenzylamide derivative (phe2) |
|
11
|
65
|
7a0fIII |
The crystal structure of bovine thrombin in complex with hirudin (c22u/c39u) at 2.7 angstroms resolution |
|
64
|
259
|
7a0dHHH |
The crystal structure of bovine thrombin in complex with hirudin (c16u/c28u) at 1.6 angstroms resolution |
|
8
|
35
|
7a0fLLL |
The crystal structure of bovine thrombin in complex with hirudin (c22u/c39u) at 2.7 angstroms resolution |
|
8
|
35
|
7a0dLLL |
The crystal structure of bovine thrombin in complex with hirudin (c16u/c28u) at 1.6 angstroms resolution |
|
8
|
64
|
7a0eIII |
The crystal structure of bovine thrombin in complex with hirudin (c6u/c14u) at 1.9 angstroms resolution |
|
65
|
259
|
7a0eHHH |
The crystal structure of bovine thrombin in complex with hirudin (c6u/c14u) at 1.9 angstroms resolution |
|
66
|
259
|
7a0fHHH |
The crystal structure of bovine thrombin in complex with hirudin (c22u/c39u) at 2.7 angstroms resolution |
|
9
|
40
|
7a0eLLL |
The crystal structure of bovine thrombin in complex with hirudin (c6u/c14u) at 1.9 angstroms resolution |
|
8
|
64
|
7a0dIII |
The crystal structure of bovine thrombin in complex with hirudin (c16u/c28u) at 1.6 angstroms resolution |
|
0
|
11
|
6y02C |
Thrombin in complex with 13k |
|
2
|
28
|
6y02L |
Thrombin in complex with 13k |
|
56
|
257
|
6y02H |
Thrombin in complex with 13k |
|
57
|
258
|
6t52H |
Thrombin in complex with a d-phe-pro-imidazole derivative |
|
1
|
28
|
6t8aL |
Thrombin in complex with diphenyl ((4-carbamimidoylphenyl)((s)-1-((r)-3-cyclohexyl 2-((phenylmethyl)sulfonamido)propanoyl)pyrrolidine-2-carboxamido)methyl)phosphonate (mi-492) |
|
63
|
258
|
6tklH |
Non-cleavable tsetse thrombin inhibitor in complex with human alpha-thrombin |
|
1
|
31
|
6tklI |
Non-cleavable tsetse thrombin inhibitor in complex with human alpha-thrombin |
|
0
|
11
|
6t52I |
Thrombin in complex with a d-phe-pro-imidazole derivative |
|
1
|
28
|
6t52L |
Thrombin in complex with a d-phe-pro-imidazole derivative |
|
7
|
36
|
6tklL |
Non-cleavable tsetse thrombin inhibitor in complex with human alpha-thrombin |
